Why Valeant Pharmaceuticals (NYSE: VRX) Stock Tanked 7% After Philidor Split

Valeant (NYSE: VRX) stock tanked 7% to $102.95 Friday. Shares sank after the company said it is ending its relationship with Philidor RX, a pharmacy used to boost sales of some of Valeant's pricey drugs. Here why the VRX stock price has further to fall.... Tags: NYSE: VRX , Philidor RX , Valeant , Valeant Pharmaceuticals , Valeant Philidor , Valeant stock , VRX , VRX stock , VRX stock price To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Why Valeant Pharmaceuticals (NYSE: VRX) Stock Tanked 7% After Philidor Split appeared first on Money Morning - We Make Investing Profitable .